Major Depressive Disorder
Resource Center
Featured
05/26/2022
Researchers examined the relationship between the use of statins and markers of depression vulnerability to better understand the antidepressant potential of these medications.
05/26/2022
05/03/2022
To resolve uncertainty about the risk-benefit ratio of electroconvulsive therapy (ECT) on suicide risk, researchers examined the impact of ECT on individuals with depression.
05/03/2022
03/16/2022
Dr Jennifer Dwyer discusses the results from her randomized, double-blind, placebo-controlled crossover trial study that found a reduction in depression scores at 24 hours post treatments with ketamine...
03/16/2022
Interactive Features
01/11/2022
Recent evidence suggests several factors may contribute to reduced response rates to serotonin-selective reuptake inhibitors in patients with major depressive disorder. Do you know which factors?
01/11/2022
04/17/2019
With current guidelines in mind, which of the following is NOT classified as a first-line treatment option for major depressive disorder?
04/17/2019
08/29/2018
The FDA recently approved a shortened version of transcranial magnetic stimulation- called theta burst stimulation- for treatment-resistant major depressive disorder. How long do shortened sessions last?
...
08/29/2018
Clinical Insights
03/16/2022
Dr Jennifer Dwyer discusses the results from her randomized, double-blind, placebo-controlled crossover trial study that found a reduction in depression scores at 24 hours post treatments with ketamine...
03/16/2022
